Role of Thrombophilic Mutations in Childhood Cardiac and Great Vessel Thrombosis

Conclusion: Our study implies not only the underlying disorders but the factor V Leiden and prothrombin G20210A mutations are the important predisposing molecular risk factors for cardiac thrombosis.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Objective: This study was conducted to analyze the thrombophilic mutations of children with cardiac and great vessel thrombosis diagnosed in our hospital and investigate the risk factors.Methods: The clinical and laboratory findings of 41 children having cardiac and/or great vessel thrombosis between 1997 and 2009 were retrospectively analyzed.

📊

Key Findings & Data:Patients with congenital heart disease were the largest group (53.7%).

💡

Conclusion & Impact:Conclusion: Our study implies not only the underlying disorders but the factor V Leiden and prothrombin G20210A mutations are the important predisposing molecular risk factors for cardiac thrombosis.

🔬Design:Research Article

📍Scope:2009 Verileri

⚙️Variables:Children · congenital heart disease · cardiac thrombosis

Abstract

Objective: This study was conducted to analyze the thrombophilic mutations of children with cardiac and great vessel thrombosis diagnosed in our hospital and investigate the risk factors.Methods: The clinical and laboratory findings of 41 children having cardiac and/or great vessel thrombosis between 1997 and 2009 were retrospectively analyzed. Results: All patients with cardiac thrombosis had an underlying associated clinical condition. The frequency of cardiac thrombosis was highest in children older than one year. Patients with congenital heart disease were the largest group (53.7%). Acquired risk factors were identified in 32 of the 41 patients. There was a significant relationship between right atrial thrombosis and wearing a central venous catheter, between right atrial thrombosis and systemic infection, between right ventricle thrombosis and angiographic procedure, and between right ventricle thrombosis and systemic infection. 33 of 41 patients (80.5%) who were examined had at least one thrombophilic mutation. Conclusion: Our study implies not only the underlying disorders but the factor V Leiden and prothrombin G20210A mutations are the important predisposing molecular risk factors for cardiac thrombosis.

Keywords

Children congenital heart disease cardiac thrombosis great vessel thrombosis thrombophilic mutations

🔖

Cite This Article

Malbora, B., Ozbek, N., Avci, Z., Verdi, H., Alioglu, B., Varan, B., Atac, F. (2014). Role of Thrombophilic Mutations in Childhood Cardiac and Great Vessel Thrombosis. Journal of Pediatric Sciences, Cilt: 6 - Sayı: 0, 1–1. https://ajindex.com/articles/836345

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (10)

Goldenberg NA, Pipe SW. Acquired disorders of hemostasis. In Nathan and Oski’s Hematology of Infancy and Childhood. 7th edition. Edited by Nathan DG, Orkin SH, Ginsburg D, Look AT. Pennsylvania: Saunders; 2009:1591-1620.
Nowak-Gottl U, Duering C, Kempf-Bielack B, Strater R. Thromboembolic diseases in neonates and children. Pathophysiol. Haemost Thromb 2004; 33(5-6):269-74.
Hanslik A, Thom K, Haumer M, Kitzmüller E, Albinni S, Wolfsberger M, Salzer-Muhar U, Male C. Incidence and diagnosis of thrombosis in children with short-term central venous lines of the upper venous system. Pediatrics 2008; 122(6):1284-91.
Tegeler CH, Downes TR. Thrombosis and the heart. Semin. Neurol. 1991; 11(4):339-52. Brugnara C. Reference values in infancy and childhood. In Nathan and Oski’s Hematology of Infancy and Childhood. 7th edition. Edited by Nathan DG, Orkin SH, Ginsburg D, Look AT. Pennsylvania: Saunders; 2009:1769-96.
Altuntas N, Soylu K, Suskan E, Akar N. Homocysteine levels in Turkish children. Turk J Hematol 2004; 21: 79– Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1998; 16(3):1215. Ozbek N, Ataç FB, Verdi H, Cetintas S, Gürakan B, Haberal A. Relationship between small-for-gestational age births and maternal thrombophilic mutations. Thromb Res 2008; 122(2):175-8.
Kinik ST, Ozbek N, Yuce M, Yazici AC, Verdi H, Ataç FB. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children. Thromb Haemos 2008; 99(2):352-6.
Akar N, Akar E, Akcay R, Avcu F, Yalcin A, Cin S. Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients. Thromb Res 2000; 97(3):163-7.
De Stefano V, Zappacosta B, Persichilli S, Rossi E, Casorelli I, Paciaroni K, Chiusolo P, Leone AM, Giardina B, Leone G. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease. Br J Haematol 1999;106(2):564-8.
Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics 2009; 124(4):1001-8.
Ozbek N, Atac FB, Yildirim SV, Verdi H, Yazici C, Yilmaz BT, Tokel NK. Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of co